UAB has received two grants totaling $3.9 million from the National Institutes of Mental Health, one of the National Institutes of Health, in an effort to better understand schizophrenia and look for new targets for therapies. McCullumsmith is the lead investigator on one of the grants. James Meador-Woodruff, M.D., chair of the Department of Psychiatry and Behavioral Neurobiology, heads the other.
The target of both is glutamate, a major neurotransmitter in the brain. The tools are cutting-edge methodologies, including laser capture micro dissection – a device that can isolate specific cells for detailed analysis – and advanced proteomics techniques that study the function and structure of proteins. The goal is to better understand why there are profound deficits in glutamate signaling and processing in the brains of those with schizophrenia.
“We know that there is something wrong with the handling of glutamate in the brains of people with schizophrenia,” says McCullumsmith. “What we don’t know is just what is wrong. Is there too much glutamate? Too little? Is it in the wrong place at the wrong time? These studies will look for those answers, and hopefully come away with new targets in the brain for medications or other therapies.”
Schizophrenia is an especially troubling condition because it usually begins in young adults between the ages of 18 and 25.
“People who previously had demonstrated relatively normal development and are in the midst of going to college, starting a family or beginning a career suddenly have deterioration in function, including social and occupational skill sets,” says Meador-Woodruff. “They typically are unable to work and have a hard time maintaining interpersonal relationships.”
More financial and community resources go toward the care and treatment of schizophrenia than any other medical illness, says McCullumsmith, and it’s an equal opportunity condition, affecting all socioeconomic segments and populations.
There are medications available to treat what are called the “positive” symptoms of schizophrenia. Positive symptoms are manifestations that a patient has that they should not have, such as hearing voices and suffering from delusions and hallucinations. Those medications, some developed more than 50 years ago, have serious side effects. The older ones can cause movement disorders; the newer versions can spur obesity, heart disease and diabetes.
There are no medications that deal with what are called “negative” symptoms – manifestations a patient should have but does not. These include grasping the concept of non-verbal communication, motivation and even understanding the need for good grooming and hygiene.
Meador-Woodruff says there are also cognitive symptoms such as decline in memory, decision making and problem solving. Again, there are no medications to treat these symptoms.
“We need new treatments for schizophrenia,” says McCullumsmith. “People with schizophrenia are often homeless, unemployed and unemployable.”
In both trials, the researchers will compare brain tissue collected from patients with schizophrenia who donated their brains to brain banks, including the Alabama Brain Collection, a tissue repository managed by Rosalinda Roberts, Ph.D., a professor of psychiatry at UAB.
Comparisons made between schizophrenic brains and normal controls may reveal changes in glutamate signaling, uptake or dispersal. Meador-Woodruff’s main focus will be on glutamate receptors on cells, while McCullumsmith’s project will look at the mechanism by which excess glutamate is removed from the brain.
“Schizophrenia is a disease that likely has many causes,” says Meador-Woodruff. “There is strong evidence that glutamate plays an important role in the development of the disease. Hopefully, these studies will help define that role and lead us to a better understanding of how to treat schizophrenia.”About UAB
EDITOR’S NOTE: The University of Alabama at Birmingham (UAB) is a separate, independent institution from the University of Alabama, which is located in Tuscaloosa. Please use University of Alabama at Birmingham on first reference and UAB on second reference.
VIDEO: www.youtube.com/uabnews TEXT: www.uab.edu/news TWEETS: www.twitter.com/uabnews
Bob Shepard | Newswise Science News
Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung
Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences